butylscopolammonium bromide has been researched along with Agranulocytosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hino, M; Koh, KR; Nakamae, H; Nakane, T; Nakao, T; Terada, Y; Yamane, T; Yoshida, N | 1 |
Hopen, G; Ly, B; Moen, T | 1 |
2 other study(ies) available for butylscopolammonium bromide and Agranulocytosis
Article | Year |
---|---|
[Chronic myelogenous leukemia complicated by drug-induced agranulocytosis].
Topics: Aged; Agranulocytosis; Benzamides; Butylscopolammonium Bromide; Colonoscopy; Female; Flumazenil; Granulocyte Colony-Stimulating Factor; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neutropenia; Piperazines; Premedication; Pyrimidines; Treatment Outcome | 2011 |
[Agranulocytosis caused by foreign analgesics (Optalidon and Nolotil)].
Topics: Administration, Oral; Agranulocytosis; Aminopyrine; Analgesics; Barbiturates; Butylscopolammonium Bromide; Caffeine; Dipyrone; Drug Combinations; Female; Humans; Middle Aged; Nonprescription Drugs; Pyrazoles; Spain | 1979 |